Reversal by Transferrin of Growth-Inhibitory Effect of Suramin on Hormone-Refractory Human Prostate Cancer Cells
Authors: S.M. Donat, C.T. Powel, R. S. Israeli, W. R. Fair, W. D. W. Heston
Journal: JNCI Journal of the National Cancer Institute (1995)

Journal Article Reversal by Transferrin of Growth-Inhibitory Effect of Suramin on Hormone-Refractory Human Prostate Cancer Cells Get access S.Machele Donat, S.Machele Donat W. D. W. Heston (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research; and Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), R. S. Israeli (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research), W. R. Fair (Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), New York, N. Y. Search for other works by this author on: Oxford Academic PubMed Google Scholar C.Thomas Powel, C.Thomas Powel W. D. W. Heston (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research; and Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), R. S. Israeli (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research), W. R. Fair (Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), New York, N. Y. Search for other works by this author on: Oxford Academic PubMed Google Scholar Ron S. Israeli, Ron S. Israeli W. D. W. Heston (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research; and Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), R. S. Israeli (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research), W. R. Fair (Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), New York, N. Y. Search for other works by this author on: Oxford Academic PubMed Google Scholar William R. Fair, William R. Fair W. D. W. Heston (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research; and Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), R. S. Israeli (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research), W. R. Fair (Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), New York, N. Y. Search for other works by this author on: Oxford Academic PubMed Google Scholar Warren D. W. Heston Warren D. W. Heston * W. D. W. Heston (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research; and Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), R. S. Israeli (Urologic Oncology Research Laboratory, Molecular Pharmacology and Therapeutics Section, Sloan-Kettering Institute for Cancer Research), W. R. Fair (Urology Service, Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center), New York, N. Y. * Correspondence to: Waren D. W. Heston, Ph.D., Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 334, New York, NY 10021. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 87, Issue 1, 4 January 1995, Pages 41–46, https://doi.org/10.1093/jnci/87.1.41 Published: 04 January 1995 Article history Received: 16 May 1994 Revision received: 24 August 1994 Accepted: 26 September 1994 Published: 04 January 1995